Rutgers, The State University of New Jersey clinical trial pipeline

5 trials changed in the last 30 days: 0 stopped, 3 with notable changes, 2 with minor changes only.

1. Notable

   SFOLFOXIRI in Advanced Gastroesophageal Cancer, (SAGE)

   Primary completion pushed from Aug 1, 2026 to Feb 1, 2027

   Also in this update: Study completion pushed from Aug 1, 2026 to Aug 1, 2027

   Rutgers, The State University of New Jersey·Phase 2· NCT05332002· Registry history of NCT05332002 on ClinicalTrials.gov (opens the registry)

   Updated Sep 23, 2026

2. Notable

   Rutgers University Study of the Genetics of Blood Cancers

   Recruitment opened

   Rutgers, The State University of New Jersey·Not specified· NCT07714044· Registry history of NCT07714044 on ClinicalTrials.gov (opens the registry)

   Updated Sep 23, 2026

3. Notable

   Implementation of a Peer Leader-facilitated Dyadic Intervention

   Study completion date changed from estimate of Jul 2025 to Jun 28, 2026

   Also in this update: Results posted: Sep 24, 2026; Completed without a posted recruiting period

   Rutgers, The State University of New Jersey·Not applicable· NCT06643806· Registry history of NCT06643806 on ClinicalTrials.gov (opens the registry)

   Updated Sep 24, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.